Fate Therapeutics, Inc. (FATE) Dividends
New to Digrin? See what a Digrin managed dividend portfolio looks like.
Sorry, we have no dividends for Fate Therapeutics, Inc. (FATE) at the moment. :(
FATE
Price: $2.41
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Ebitda: -10.1 millionMarket Capitalization: 340.4 million